One of the outpatient rehab options for people in Mexico struggling with opioid dependence and addiction is called opioid maintenance therapy. Some centers and doctors are certified to dispense specific medications to opioid dependent individuals, many of which are opioid-based also and are habit forming. With low enough doses the client doesn't experience being high and also doesn't have intense cravings and isn't in opioid withdrawal. Methadone is the first medication used for this reason, but there are other choices currently to pick from.
Methadone is an opiate and can be taken at an out-patient medical center certified to dispense the med, which is taken daily in liquid or pill form. The cost of the drug is approximately $150 per month. Buprenorphine is also an opiate based med, and is in pill form often taken one day on, one day off. But unlike Methadone which is only be given in highly well-regulated medical centers, Buprenorphine can be prescribed and administered in doctor's offices. The price monthly of buprenorphine is about $300.00 per month for the generic version of the med. There is also a type of buprenorphine that contains the ingredient naloxone, that is a med which blocks the effects of opioids. An individual taking this version of the drug, also known as Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It too is taken daily, and costs about $450 a month. Naltrexone is another drug taken in opioid maintenance therapy, but unlike the other drugs mentioned here it is an opioid blocker and isn't an opioid. A person has the choice to take this medication as a monthly injection, and that is called Vivitrol. As an opioid blocker, it prevents someone from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 a month.
There are 1 Drug and Alcohol Rehabilitation Facilities offering this service in Mexico, MO
For All Drug and Alcohol Rehab Programs In Mexico, Click Here.